1. AB0531 Decision to initiate immunosuppression in patients with primary sjogren's syndrome. (12th June 2018) Authors: Daia-Iliescu, S.; Buzatu, C.; Gudu, T.; Zaharia, D.; Purice, C.; Borangiu, A.; Saulescu, I.; Groseanu, L.; Constantinescu, C.; Negru, M.M.; Vlad, V.; Bojinca, V.; Berghea, F.; Balanescu, A.; Predeteanu, D.; Ionescu, R.; Opris-Belinski, D. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0557 Haematological involvement (CYTOPENIA) at the time of the diagnosis is associated with less severe ocular involvement in patients with primary sjogren syndrome. (12th June 2018) Authors: Buzatu, C.G.; Daia-Iliescu, S.; Saulescu, I.; Zaharia, D.; Purice, C.; Gudu, T.; Borangiu, A.; Groseanu, L.; Bojinca, V.; Berghea, F.; Balanescu, A.; Predeteanu, D.; Ionescu, R.; Opris-Belinski, D. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Benign form of atrophic papulosis developed at injection sites of pegylated‐alpha‐interferon: is there a pathophysiological link?. (1st April 2014) Authors: Zaharia, D.; Truchot, F.; Ronger‐Savle, S.; Balme, B.; Thomas, L. Journal: British journal of dermatology Issue: Volume 170:Number 4(2014:Apr.) Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Benign form of atrophic papulosis developed at injection sites of pegylated‐alpha‐interferon: is there a pathophysiological link?. (April 2014) Authors: Zaharia, D.; Truchot, F.; Ronger‐Savle, S.; Balme, B.; Thomas, L. Journal: British journal of dermatology Issue: Volume 170:Number 4(2014:Apr.) Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cernavoda Tritium Removal Facility—Evolution in TRF Design. (3rd April 2017) Authors: Stefan, L.; Trantea, N.; Roberts, A.; Strikwerda, S.; Antoniazzi, A.; Zaharia, D. Journal: Fusion science and technology Issue: Volume 71:Number 3(2017) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sarcoidosis associated with vemurafenib. (8th July 2013) Authors: Adam, A.; Thomas, L.; Bories, N.; Zaharia, D.; Balme, B.; Freymond, N.; Dalle, S. Journal: British journal of dermatology Issue: Volume 169:Number 1(2013:Jul.) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗